{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T18:40:21Z","timestamp":1777747221773,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:00:00Z","timestamp":1679097600000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ajem.2022.03.024","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T20:26:37Z","timestamp":1647635197000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review"],"prefix":"10.1016","volume":"56","author":[{"given":"Michael","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Figlewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willeed","family":"Rabah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devon","family":"Buddan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2022.03.024_bb0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1097-0142(195901\/02)12:1<164::AID-CNCR2820120122>3.0.CO;2-Y","article-title":"Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas","volume":"12","author":"Saltzstein","year":"1959","journal-title":"Cancer."},{"issue":"693","key":"10.1016\/j.ajem.2022.03.024_bb0010","first-page":"e1","article-title":"DRESS syndrome: part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0015","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM195006082422304","article-title":"Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis","volume":"242","author":"Chaiken","year":"1950","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2022.03.024_bb0020","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk","volume":"82","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajem.2022.03.024_bb0025","first-page":"357","article-title":"The drug hypersensitivity syndrome: what is the pathogenesis?","volume":"137","author":"Sullivan","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002018-199921060-00005","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention and management","volume":"21","author":"Knowles","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajem.2022.03.024_bb0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.024_bb0040","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"RegiSCAR study group. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ajem.2022.03.024_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ajem.2022.03.024_bb0050","unstructured":"Muller P, Dubreil P, Mah\u00e9 A, Lamaury I, Salzer B, Deloumeaux J, Strobel M. Drug hypersensitivity syndrome in a West-Indian population. Eur J Dermatol 2003 Sep-Oct;13(5):478\u201381."},{"key":"10.1016\/j.ajem.2022.03.024_bb0055","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.024_bb0060","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2133.2003.05584.x","article-title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","volume":"149","author":"Fiszenson-Albala","year":"2003","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.ajem.2022.03.024_bb0065","first-page":"767","article-title":"Cutaneous adverse drug reactions in hospitalised patients","volume":"51","author":"Lee","year":"2010","journal-title":"Singap Med J"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.024_bb0070","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1111\/bjd.15461","article-title":"Cutaneous adverse drug reaction referrals to a liaison dermatology service","volume":"177","author":"Teo","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.024_bb0075","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jaad.2020.03.081","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: a systematic review of the literature","volume":"83","author":"Kim","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.024_bb0085","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaad.2017.05.041","article-title":"Vancomycin and DRESS: a retrospective chart review of 32 cases in Los Angeles, California","volume":"77","author":"Lam","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.ajem.2022.03.024_bb0090","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jid.2016.02.808","article-title":"Taiwan severe cutaneous adverse reaction consortium. Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions","volume":"136","author":"Ng","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0095","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1592\/phco.27.10.1425","article-title":"Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care","volume":"27","author":"Bohan","year":"2007","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.ajem.2022.03.024_bb0100","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-4632.2008.03637.x","article-title":"Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review","volume":"47","author":"Ganeva","year":"2008","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.ajem.2022.03.024_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","article-title":"Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity","volume":"105","author":"Shear","year":"1986","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ajem.2022.03.024_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.1991.3","article-title":"Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions","volume":"49","author":"Rieder","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ajem.2022.03.024_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int"},{"issue":"46","key":"10.1016\/j.ajem.2022.03.024_bb0125","doi-asserted-by":"crossref","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.024_bb0130","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ajem.2022.03.024_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0140","first-page":"301","article-title":"Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms","volume":"137","author":"Descamps","year":"2001","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.024_bb0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1346-8138.2005.tb00762.x","article-title":"Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation","volume":"32","author":"Sekiguchi","year":"2005","journal-title":"J Dermatol"},{"issue":"11","key":"10.1016\/j.ajem.2022.03.024_bb0150","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jdv.13212","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases","volume":"29","author":"Skowron","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Pt 6","key":"10.1016\/j.ajem.2022.03.024_bb0155","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1099\/0022-1317-76-6-1409","article-title":"Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication","volume":"76","author":"Kuntz-Simon","year":"1995","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jdermsci.2011.12.002","article-title":"The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity","volume":"65","author":"Hanafusa","year":"2012","journal-title":"J Dermatol Sci"},{"issue":"9","key":"10.1016\/j.ajem.2022.03.024_bb0165","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/jid.2015.165","article-title":"Oxypurinol-specific T cells possess preferential TCR Clonotypes and express Granulysin in allopurinol-induced severe cutaneous adverse reactions","volume":"135","author":"Chung","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0170","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaip.2016.10.009","article-title":"Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: an immunohistochemical study","volume":"5","author":"Hansel","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.ajem.2022.03.024_bb0175","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/bjd.14839","article-title":"Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome","volume":"176","author":"Ye","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MD.0b013e3181a4d1a1","article-title":"Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients","volume":"88","author":"Ben M\u2019rad","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.ajem.2022.03.024_bb0185","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0190","doi-asserted-by":"crossref","unstructured":"Darlenski R, Kazandjieva J, Tsankov N. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS. Clin Dermatol 2015 Sep-Oct;33(5):538\u201341.","DOI":"10.1016\/j.clindermatol.2015.05.005"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: a retrospective study","volume":"82","author":"Soria","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0200","first-page":"1","article-title":"Updates and insights in the diagnosis and management of DRESS syndrome","author":"Schunkert","year":"2021","journal-title":"Curr Dermatol Rep"},{"key":"10.1016\/j.ajem.2022.03.024_bb0205","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjd.12081","article-title":"Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases","volume":"168","author":"Walsh","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2021.04.020","article-title":"Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: facial edema aligns to the severe phenotype","volume":"85","author":"Momen","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"19","key":"10.1016\/j.ajem.2022.03.024_bb0215","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"issue":"2019","key":"10.1016\/j.ajem.2022.03.024_bb0220","first-page":"7863815","article-title":"Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"24","author":"Taweesedt","year":"2019","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.ajem.2022.03.024_bb0225","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2013.03.024","article-title":"Characteristics of liver injury in drug-induced systemic hypersensitivity reactions","volume":"69","author":"Lee","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0235","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0240","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4168\/aair.2014.6.3.216","article-title":"Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"6","author":"Kim","year":"2014","journal-title":"Allergy, Asthma Immunol Res"},{"key":"10.1016\/j.ajem.2022.03.024_bb0245","doi-asserted-by":"crossref","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part II. management and therapeutics. J Am Acad Dermatol 2013;68(5):709.e1\u2013720.","DOI":"10.1016\/j.jaad.2013.01.032"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review","volume":"77","author":"Sharifzadeh","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.024_bb0255","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand","volume":"65","author":"Hiransuthikul","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.ajem.2022.03.024_bb0260","doi-asserted-by":"crossref","first-page":"978","DOI":"10.12659\/AJCR.909569","article-title":"Myocarditis associated with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report and review of the literature","volume":"19","author":"Morikawa","year":"2018","journal-title":"Am J Case Rep"},{"issue":"2","key":"10.1016\/j.ajem.2022.03.024_bb0265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/1346-8138.12378","article-title":"Drug-induced hypersensitivity syndrome due to minocycline complicated by severe myocarditis","volume":"41","author":"Kanno","year":"2014","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0270","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1684\/ejd.2011.1300","article-title":"Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone","volume":"21","author":"Natkunarajah","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"11","key":"10.1016\/j.ajem.2022.03.024_bb0275","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.annder.2010.04.024","article-title":"Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS) [management of drug reaction with eosinophilia and systemic symptoms (DRESS)]","volume":"137","author":"Descamps","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2334-10-49","article-title":"Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review","volume":"10","author":"Gentile","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ajem.2022.03.024_bb0285","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2340\/00015555-1168","article-title":"High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome","volume":"92","author":"Kito","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.ajem.2022.03.024_bb0290","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1542\/peds.107.1.e14","article-title":"Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin","volume":"107","author":"Scheuerman","year":"2001","journal-title":"Pediatrics."},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0295","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.SMJ.0000054501.05278.5F","article-title":"Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin","volume":"97","author":"Mostella","year":"2004","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.024_bb0300","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/08830738060210051301","article-title":"Treatment of anticonvulsant hypersensitivity syndrome with intravenous immunoglobulins and corticosteroids","volume":"21","author":"Prais","year":"2006","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.024_bb0305","first-page":"510","article-title":"Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG)","volume":"4","author":"Fields","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.024_bb0310","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.148.4.dlt120002-c","article-title":"Poor benefit\/risk balance of intravenous immunoglobulins in DRESS","volume":"148","author":"Joly","year":"2012","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.ajem.2022.03.024_bb0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tox.2004.12.013","article-title":"Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome","volume":"209","author":"Kano","year":"2005","journal-title":"Toxicology."},{"issue":"2","key":"10.1016\/j.ajem.2022.03.024_bb0320","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5414\/CNP64155","article-title":"Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment","volume":"64","author":"Zuliani","year":"2005","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.024_bb0325","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.ajkd.2009.10.054","article-title":"Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation","volume":"55","author":"Laban","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.ajem.2022.03.024_bb0330","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamadermatol.2016.2220","article-title":"Cyclosporine treatment of drug-induced hypersensitivity syndrome","volume":"152","author":"Kirchhof","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0335","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.1997.tb02175.x","article-title":"Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis: treatment with N-acetylcysteine","volume":"136","author":"Redondo","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0340","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2133.1998.02150.x","article-title":"Hazards of therapy with high doses of N-acetylcysteine for anticonvulsant-induced hypersensitivity syndrome","volume":"138","author":"Simonart","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajem.2022.03.024_bb0345","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mjd.2002.118557","article-title":"Toxic epidermal necrolysis treated with N-acetylcysteine","volume":"46","author":"V\u00e9lez","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.024_bb0350","article-title":"Drug reaction, eosinophilia, and systemic symptoms (DRESS) syndrome as a mimicker of spinal infection: awareness for spinal surgeons","volume":"12","author":"Mohammed","year":"2020","journal-title":"Cureus."}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:59:05Z","timestamp":1760025545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":70,"alternative-id":["S0735675722001814"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.03.024","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}